Lung cancer screening

Zeitschrift für Pneumologie - Tập 20 Số 5 - Trang 244-257 - 2023
Dennis Ladage1, Stefan Delorme2
1Klinik für Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin, Kliniken Maria Hilf Mönchengladbach, Mönchengladbach, Deutschland
2Abt. Radiologie (E010), Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Robert Koch-Institut (2021) Datenbankabfrage mit Schätzung der Inzidenz, Prävalenz und des Überlebens von Krebs in Deutschland auf Basis der epidemiologischen Landeskrebsregisterdaten. https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Lungenkrebs/lungenkrebs_node.html. Zugegriffen: 7. Okt. 2021

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Osann KE, Anton-Culver H, Kurosaki T, Taylor T (1993) Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 54(1):44–48

Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2018) Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. http://leitlinienprogramm-onkologie.de/Lungenkarzinom.98.0.html (AWMF-Registernummer: 020/007OL). Zugegriffen: 7. Okt. 2021

Mons U, Gredner T, Behrens G, Stock C, Brenner H (2018) Cancers due to smoking and high alcohol consumption. Dtsch Arztebl Int 115(35–36):571–577

Seitz N‑N, John L, Atzendorf J, Rauschert C, Kraus L (2018) Kurzbericht Epidemiologischer Suchtsurvey 2018. Tabakkonsum und Hinweise auf Konsumabhängigkeit nach Geschlecht und Alter im Jahr 2018

Kotz D, Bockmann M, Kastaun S (2018) The use of tobacco, E‑cigarettes, and methods to quit smoking in Germany. Dtsch Arztebl Int 115(14):235–242

Kaaks R, Delorme S (2021) Lung cancer screening by low-dose computed tomography—part 1: expected benefits, possible harms, and criteria for eligibility and population targeting. Rofo 193(5):527–536

van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ (2011) The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J 37(6):1466–1473

Pistelli F, Aquilini F, Falaschi F, Puliti D, Ocello C, Lopes Pegna A et al (2020) Smoking cessation in the ITALUNG lung cancer screening: what does „teachable moment“ mean? Nicotine Tob Res 22(9):1484–1491

Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM et al (2018) Lung cancer screening and smoking cessation clinical trials. SCALE (smoking cessation within the context of lung cancer screening) collaboration. Am J Respir Crit Care Med 197(2):172–182

Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321(7257):323–329

Wakai K, Marugame T, Kuriyama S, Sobue T, Tamakoshi A, Satoh H et al (2007) Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies. Cancer Sci 98(4):584–589

Becker N, Motsch E, Trotter A, Heussel CP, Dienemann H, Schnabel PA et al (2020) Lung cancer mortality reduction by LDCT screening-results from the randomized German LUSI trial. Int J Cancer 146(6):1503–1513

Delorme S, Kaaks R (2021) Lung cancer screening by low-dose computed tomography: part 2—key elements for programmatic implementation of lung cancer screening. Rofo 193(6):644–651

Napel S, Rubin GD, Jeffrey RB Jr. (1993) STS-MIP: a new reconstruction technique for CT of the chest. J Comput Assist Tomogr 17(5):832–838

de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382(6):503–513

Horeweg N, Nackaerts K, Oudkerk M, de Koning HJ (2013) Low-dose computed tomography screening for lung cancer: results of the first screening round. J Comp Eff Res 2(5):433–436

Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F et al (2017) Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax 72(9):825–831

Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S et al (1994) Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958–1987. Radiat Res 137(2):S17–67

Mascalchi M, Mazzoni LN, Falchini M, Belli G, Picozzi G, Merlini V et al (2012) Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol 85(1016):1134–1139

Albert JM (2013) Radiation risk from CT: implications for cancer screening. AJR Am J Roentgenol 201(1):W81–7

Cressman S, Peacock SJ, Tammemagi MC, Evans WK, Leighl NB, Goffin JR et al (2017) The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency. J Thorac Oncol 12(8):1210–1222

Gesierich WJ, Darwiche K, Dollinger F, Eberhardt R, Eisenmann S, Grah C et al (2021) Joint statement of the German respiratory society and German society of thoracic surgery in cooperation with the German radiological society: structural prerequisites of centres for Interventional treatment of emphysema. Respiration 100(1):52–58

Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409